DividendMapper
Viatris Inc. logo

VTRS

Viatris Inc.

  • Healthcare
  • US companies in Healthcare (47)
  • NASDAQ · USD
  • Mkt cap $20.7bn

$18.00

as of 23 Oct 2026, 4% below its 52-week high

Screens as less well placed to keep growing its dividend, though its cut-risk signals are low. Its valuation looks somewhat extended against its own history.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield
2.67%Last 12 months of regular payments at today's price
Forward yield
2.67%Each payment expected in the next 12 months, not the latest one doubled
Earnings cover
Not availableEarnings over dividends paid
Cash cover
3.4×Free cash flow over dividends paid
5y dividend growth
Not availableLast cut in FY2020
Next ex-dividend date
Estimated24 Nov 2026Quarterly dividend of about $0.12

Compared with US companies in Healthcare (47)

  • Trailing yield is higher than 43 of the 46 other US companies in Healthcare.

Quality

47

Low

Capacity to keep growing the dividend

Risk

30

Low

Signals of dividend-cut pressure

Trim

56

Moderate

How extended the valuation looks

Why Quality is 47

VTRS against US companies in Healthcare (47)

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of VTRS’s past readings.

  • P/E-39.7×P8, good for this measure
  • Yield3.02%P59, neutral for this measure
  • FCF payout29.8%P81, poor for this measure
  • Net debt / EBITDA17.48P55, neutral for this measure
  • DGR 5y+34.3%P50, neutral for this measure
  • ROIC0.0%P33, neutral for this measure
Open valuation history

Forecast your income with the VTRS dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.